Maxalt-Mlt Related Published Studies
Well-designed clinical trials related to Maxalt-Mlt (Rizatriptan)
Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. [2011.05]
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. [2011.04]
Rizatriptan reduces vestibular-induced motion sickness in migraineurs. [2011.02]
Efficacy of frovatriptan in the acute treatment of menstrually related migraine:
analysis of a double-blind, randomized, cross-over, multicenter, Italian,
comparative study versus rizatriptan. [2011]
A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. [2009.08.06]
Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response. [2009.05]
Migraine treatment with rizatriptan and almotriptan: a crossover study. [2009.05]
Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis. [2009.03]
Memantine in the preventive treatment of refractory migraine. [2008.10]
Effects of rizatriptan on the contingent negative variation in healthy women. [2008.09]
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. [2008.09]
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. [2008.06]
Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial. [2008.03]
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. [2008.02]
Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies. [2007.09]
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. [2007.06]
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. [2007.05]
Patient preference in migraine therapy : A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan. [2007.02]
Well-designed clinical trials possibly related to Maxalt-Mlt (Rizatriptan)
Gender and triptan efficacy: a pooled analysis of three double-blind, randomized,
crossover, multicenter, Italian studies comparing frovatriptan vs. other
triptans. [2014]
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of
hypertensive and normotensive subjects: a review of randomized studies. [2013]
Frovatriptan vs. other triptans for the acute treatment of oral
contraceptive-induced menstrual migraine: pooled analysis of three double-blind,
randomized, crossover, multicenter studies. [2013]
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in
adults. [2012]
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. [2011.01]
Published and not fully published double-blind, randomised, controlled trials
with oral naratriptan in the treatment of migraine: a review based on the GSK
Trial Register. [2011]
A comparison of migraine patients with and without allodynic symptoms. [2009.10]
Acute treatment and prevention of menstrually related migraine headache: evidence-based review. [2008.04.22]
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. [2008.04.15]
Traditional acupuncture in migraine: a controlled, randomized study. [2008.03]
Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study. [2007.10.18]
Other research related to Maxalt-Mlt (Rizatriptan)
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in
patients with moderate-to-severe migraine. [2014]
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a
double-blind trial. [2012]
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. [2011.12]
Rizatriptan for Treatment of Acute Migraine in Patients Taking Topiramate for Migraine Prophylaxis. [2011.11.11]
Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks. [2011.11]
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database. [2011.03]
Rizatriptan reduces vestibular-induced motion sickness in migraineurs. [2011]
Rizatriptan reduces vestibular-induced motion sickness in migraineurs. [2010.09.23]
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. [2010.08.05]
Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan. [2010.06]
Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis. [2010.04]
Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. [2009.10]
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults. [2009.07]
Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior. [2009.02]
Ten years of rizatriptan: from development to clinical science and future directions. [2009.02]
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future. [2008.04]
WITHDRAWN: Rizatriptan for acute migraine. [2007.07.18]
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. [2007.07]
Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats. [2007.06.07]
Association study between clinical response to rizatriptan and some candidate genes. [2007.06]
Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate. [2007.03]
Other possibly related research studies
Prescribing for migraine with the focus on selective 5HT1-receptor agonists: a pharmacy database analysis. [2010.05]
Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. [2010.04]
Expanding access to triptans: assessment of clinical outcome. [2009.11]
A study of triggers of migraine in India. [2010.01]
Individual triptan selection in migraine attack therapy. [2009.01]
Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation. [2008.10]
Treatment of children with migraine in the emergency department: a qualitative systematic review. [2008.05]
Use of 5-HT1 agonists in pregnancy. [2008.04]
Triptans in pregnancy. [2008.02]
Almotriptan, an antimigraine agent, and its malate salt. [2008.01]
Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. [2008.02]
Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. [2007.09]
Acute treatment of paediatric migraine: A meta-analysis of efficacy. [2008.01]
Treatment of hemiplegic migraine with triptans. [2007.09]
Economic analysis of triptan therapy for acute migraine: a Medicaid perspective. [2007.08]
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. [2007.06]
The cost-effectiveness of oral triptan therapy in Sweden. [2007.01]
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. [2007]
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people. [2011.06]
Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007. [2011.06]
Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. [2011.05]
Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. [2011.08]
Triptans other than sumatriptan in child and adolescent migraine: literature review. [2011.03]
Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine. [2011.01]
Acute management of migraine. [2010.04]
The use of triptans for pediatric migraines. [2010.12.01]
Prevention and treatment of menstrual migraine. [2010.10.01]
Triptans for the management of migraine. [2010.08.20]
Brain apparent water diffusion coefficient magnetic resonance image during a prolonged visual aura. [2010.06]
Entry demographics and pharmacological treatment of migraine patients referred to a tertiary care pain clinic. [2010.01]
Excellent tolerability but relatively low initial clinical efficacy of
telcagepant in migraine. [2011]
The use of triptans for pediatric migraines. [2010]
Altered placebo and drug labeling changes the outcome of episodic migraine
attacks. [2014]
Comparative efficacy of triptans for the abortive treatment of migraine: a
multiple treatment comparison meta-analysis. [2014]
Migraine therapeutics in adolescents: a systematic analysis and historic
perspectives of triptan trials in adolescents. [2013]
Efficacy of intravenous propacetamol hydrochloride in the treatment of an acute
attack of migraine. [2014]
|
